Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1017746510 | 10177465 | 10 | F | 20140504 | 20151223 | 20140516 | 20151231 | EXP | PHHY2012CA073848 | NOVARTIS | 49.73 | YR | M | Y | 0.00000 | 20160101 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1017746510 | 10177465 | 1 | PS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 30 MG, (QMO) EVERY 4 WEEKS | 345482 | 21008 | 30 | MG | /month |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 1017746510 | 10177465 | 1 | Neuroendocrine tumour |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 1017746510 | 10177465 | OT |
| 1017746510 | 10177465 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 1017746510 | 10177465 | Abdominal pain upper | |
| 1017746510 | 10177465 | Anxiety | |
| 1017746510 | 10177465 | Blood pressure increased | |
| 1017746510 | 10177465 | Decreased appetite | |
| 1017746510 | 10177465 | Dizziness | |
| 1017746510 | 10177465 | Dry eye | |
| 1017746510 | 10177465 | Dry mouth | |
| 1017746510 | 10177465 | Dry skin | |
| 1017746510 | 10177465 | Erythema | |
| 1017746510 | 10177465 | Fatigue | |
| 1017746510 | 10177465 | Flushing | |
| 1017746510 | 10177465 | Gastrointestinal disorder | |
| 1017746510 | 10177465 | Haemophilia | |
| 1017746510 | 10177465 | Headache | |
| 1017746510 | 10177465 | Hearing impaired | |
| 1017746510 | 10177465 | Heart rate increased | |
| 1017746510 | 10177465 | Heart rate irregular | |
| 1017746510 | 10177465 | Injection site haemorrhage | |
| 1017746510 | 10177465 | Injection site mass | |
| 1017746510 | 10177465 | Injection site pain | |
| 1017746510 | 10177465 | Malaise | |
| 1017746510 | 10177465 | Metastases to spine | |
| 1017746510 | 10177465 | Micturition urgency | |
| 1017746510 | 10177465 | Myalgia | |
| 1017746510 | 10177465 | Nausea | |
| 1017746510 | 10177465 | Needle issue | |
| 1017746510 | 10177465 | Peripheral swelling | |
| 1017746510 | 10177465 | Pleural effusion | |
| 1017746510 | 10177465 | Pneumonia | |
| 1017746510 | 10177465 | Pollakiuria | |
| 1017746510 | 10177465 | Rhinorrhoea | |
| 1017746510 | 10177465 | Sleep disorder | |
| 1017746510 | 10177465 | Stress | |
| 1017746510 | 10177465 | Sunburn | |
| 1017746510 | 10177465 | Underdose | |
| 1017746510 | 10177465 | Upper extremity mass | |
| 1017746510 | 10177465 | Venous injury | |
| 1017746510 | 10177465 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 1017746510 | 10177465 | 1 | 20120405 | 0 |